▲ BUY
4
/ 10
Conviction
$ Value
$585
Shares
3
Price
$195
Filed
Feb 17
▶ Why this score? (4/10)
- ✓ Open market buy (+3)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
Murphy Nicole
Title
Head of Pharm Ops and Tech
CIK
0001910644
Roles
Officer
Transaction Details
Transaction Date
2026-02-12
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
19,611
Footnotes
The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 13, 2026.
Filing Info
Murphy Nicole's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-13 | BIIB | A | $0 |
| 2026-02-12 | BIIB | ▲ | $585 ★ |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $205K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $184K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | F | $283K |
| 2026-02-06 | BIIB | M | $0 |
| 2026-02-06 | BIIB | M | $0 |
Other Insiders at BIIB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
ALEXANDER SUSAN H
EVP Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gregory Ginger
EVP, Human Resources
|
— | — | 2026-02-13 |
|
Kramer Robin
Chief Financial Officer
|
— | — | 2026-02-13 |
|
Singhal Priya
Head of Development
|
— | $666K | 2026-02-13 |
|
Viehbacher Christopher
President and CEO
|
— | — | 2026-02-13 |
|
Izzar Rachid
Head of Global Product Strat.
|
— | — | 2026-02-13 |
|
Murphy Nicole
Head of Pharm Ops and Tech
|
— | — | 2026-02-13 |
|
Keeney Adam
Head of Corporate Development
|
— | — | 2026-02-13 |
|
Grogan Jane
Head of Research
|
— | — | 2026-02-13 |
|
Godbout Sean
Chief Accounting Officer
|
— | — | 2026-04-01 |